Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taspoglutide vs Pioglitazone in Type 2 Diabetes (T-emerge 6)
NCT00909597Phase 3Completed
- Sponsor
- Roche
- Start
- May 2009
- Primary completion
- Nov 2010
- Modality
- Peptides
- Countries
- 19
01
Overview
A Phase 3 trial of taspoglutide in type 2 diabetes mellitus (T2DM), sponsored by Roche. Started May 2009; status: completed.
02
Drugs
taspoglutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00909597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00909597.